Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data.
QSAR (qualitative structure-activity relationships)
chemoinformatics
drug synergy
machine learning
predictive (QSPR) models
Journal
Frontiers in chemistry
ISSN: 2296-2646
Titre abrégé: Front Chem
Pays: Switzerland
ID NLM: 101627988
Informations de publication
Date de publication:
2019
2019
Historique:
received:
17
05
2019
accepted:
02
07
2019
entrez:
6
8
2019
pubmed:
6
8
2019
medline:
6
8
2019
Statut:
epublish
Résumé
Drug combinations are of great interest for cancer treatment. Unfortunately, the discovery of synergistic combinations by purely experimental means is only feasible on small sets of drugs.
Identifiants
pubmed: 31380352
doi: 10.3389/fchem.2019.00509
pmc: PMC6646421
doi:
Types de publication
Journal Article
Langues
eng
Pagination
509Références
Nature. 2013 Dec 19;504(7480):389-93
pubmed: 24284626
Sci Rep. 2015 Nov 25;5:16991
pubmed: 26601688
Eur J Pharm Sci. 2012 Aug 30;47(1):273-9
pubmed: 22538055
Bioorg Med Chem. 2011 Nov 1;19(21):6239-44
pubmed: 21967806
Bioorg Med Chem. 2011 Mar 15;19(6):2090-102
pubmed: 21354800
J Natl Cancer Inst. 2013 Oct 2;105(19):1441-56
pubmed: 24052618
Nature. 2016 May 18;533(7603):333-7
pubmed: 27193678
Science. 2014 Dec 19;346(6216):1480-6
pubmed: 25394791
PLoS One. 2015 Mar 20;10(3):e0120408
pubmed: 25794193
Crit Rev Oncol Hematol. 2001 Jan;37(1):69-82
pubmed: 11164721
Biol Direct. 2015 Mar 25;10:10
pubmed: 25880749
Nature. 2015 Dec 3;528(7580):84-7
pubmed: 26570998
J Chem Inf Comput Sci. 2003 Nov-Dec;43(6):1947-58
pubmed: 14632445
Nature. 2016 Nov 30;540(7631):E2-E4
pubmed: 27905430
PLoS One. 2013 Apr 30;8(4):e61318
pubmed: 23646105
Science. 2010 May 21;328(5981):1031-5
pubmed: 20378772
Oncotarget. 2017 Sep 15;8(57):97025-97040
pubmed: 29228590
J Comput Aided Mol Des. 2005 Sep-Oct;19(9-10):693-703
pubmed: 16292611
Mol Inform. 2016 May;35(5):160-80
pubmed: 27492083
Biophys Rev. 2019 Feb;11(1):31-39
pubmed: 30097794
Drug Discov Today. 2016 Feb;21(2):225-38
pubmed: 26360051
BMC Bioinformatics. 2018 Dec 21;19(Suppl 18):486
pubmed: 30577754
Cancer Res. 2017 Jul 1;77(13):3564-3576
pubmed: 28446463
Eur J Med Chem. 2007 May;42(5):580-5
pubmed: 17207560
J Comput Aided Mol Des. 2008 Jun-Jul;22(6-7):403-21
pubmed: 18253701
Eur J Med Chem. 2010 Mar;45(3):1113-8
pubmed: 20056518
PeerJ. 2017 Mar 2;5:e3030
pubmed: 28265509
Mol Cancer Ther. 2016 Jun;15(6):1155-62
pubmed: 26983881
Oncotarget. 2017 Jun 6;8(23):38022-38043
pubmed: 28410237
Anticancer Drugs. 2012 Mar;23(3):272-9
pubmed: 23427335
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10750-10755
pubmed: 30282735
Adv Enzyme Regul. 1984;22:27-55
pubmed: 6382953
Nat Commun. 2019 Jun 17;10(1):2674
pubmed: 31209238
Bioinformatics. 2018 May 1;34(9):1538-1546
pubmed: 29253077
Mol Inform. 2012 Apr;31(3-4):202-21
pubmed: 27477092
Sci Rep. 2014 Apr 14;4:4668
pubmed: 24728108
Nat Rev Cancer. 2013 Oct;13(10):714-26
pubmed: 24060863
Nat Rev Cancer. 2006 Oct;6(10):813-23
pubmed: 16990858
J Chem Inf Model. 2016 Dec 27;56(12):2353-2360
pubmed: 27958738
J Med Chem. 2014 Jun 26;57(12):4977-5010
pubmed: 24351051
PLoS One. 2015 Jul 01;10(7):e0127433
pubmed: 26132924
Cancer Res. 2018 Sep 15;78(18):5446-5457
pubmed: 30054332
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
J Comput Aided Mol Des. 2013 Aug;27(8):675-9
pubmed: 23963658
Nature. 2016 Nov 30;540(7631):E1-E2
pubmed: 27905415
Pharmacol Res Perspect. 2015 Jun;3(3):e00149
pubmed: 26171228
Pharmacol Rev. 1995 Jun;47(2):331-85
pubmed: 7568331
J Chem Inf Model. 2014 Aug 25;54(8):2347-59
pubmed: 25046554
J Chem Inf Model. 2010 May 24;50(5):742-54
pubmed: 20426451
Bioinformatics. 2016 Sep 15;32(18):2866-8
pubmed: 27153664
J Chem Inf Model. 2012 Sep 24;52(9):2325-38
pubmed: 22894688
Front Chem. 2019 Jul 16;7:509
pubmed: 31380352
F1000Res. 2016 Sep 16;5:2333
pubmed: 28928933
J Chem Inf Model. 2013 Nov 25;53(11):2837-50
pubmed: 24152204
Sci Rep. 2015 Sep 22;5:14118
pubmed: 26392291